Literature DB >> 9490684

A common genetic polymorphism (46 C to T substitution) in the 5'-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level.

T Kanaji1, T Okamura, K Osaki, M Kuroiwa, K Shimoda, N Hamasaki, Y Niho.   

Abstract

We studied the Hga I polymorphism (46 C/T) in the 5'-untranslated region of the coagulation factor XII (FXII) gene corresponding to four bases upstream from the ATG translation initiation codon. By using allele-specific restriction analysis with restriction endonuclease Hga I, the allele frequency of 46C/T was estimated to be 0.27/0.73 in Orientals (allele number =152), and conversely, 0.8/0.2 in Caucasians (allele number =40). Because it has been reported that plasma levels of FXII were lower in Orientals than in Caucasians, we investigated the relationship between this polymorphism and plasma levels of FXII. As a result, there were significant differences in plasma FXII levels between these three allele types: C/C,170+/-38% (178+/-27%); C/T, 141+/-29% (123+/-34%); and T/T, 82+/-19% (61+/-11%) [FXII activity (FXII antigen levels)]. In heterozygotes of 46 C/T both alleles were equally transcribed in hepatocytes, as determined by reverse transcription polymerase chain reaction (RT-PCR), suggesting little influence of the polymorphism at the level of transcription or on the stability of mRNA. In in vitro transcription/translation analysis, less FXII was produced from cDNA containing 46 T than from that containing 46 C. Therefore, it is highly likely that the 46 T polymorphism in the FXII gene decreased the translation efficiency and led to low plasma levels of FXII activity and antigen, probably due to the creation of another ATG codon and/or impairment of the consensus sequence for the translation initiation scanning model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490684

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

Review 1.  Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation.

Authors:  Toshiyuki Miyata; Rina Kimura; Yoshihiro Kokubo; Toshiyuki Sakata
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease.

Authors:  José Manuel Soria; Laura Almasy; Juan Carlos Souto; Delphine Bacq; Alfonso Buil; Alexandra Faure; Elisabeth Martínez-Marchán; José Mateo; Montserrat Borrell; William Stone; Mark Lathrop; Jordi Fontcuberta; John Blangero
Journal:  Am J Hum Genet       Date:  2002-01-22       Impact factor: 11.025

3.  Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels.

Authors:  Francesc Calafell; Laura Almasy; Maria Sabater-Lleal; Alfonso Buil; Carolina Mordillo; Anna Ramírez-Soriano; Martin Sikora; Juan Carlos Souto; John Blangero; Jordi Fontcuberta; José Manuel Soria
Journal:  Hum Mol Genet       Date:  2009-11-23       Impact factor: 6.150

4.  The Mediterranean Sea as a barrier to gene flow: evidence from variation in and around the F7 and F12 genomic regions.

Authors:  Georgios Athanasiadis; Emili González-Pérez; Esther Esteban; Jean-Michel Dugoujon; Mark Stoneking; Pedro Moral
Journal:  BMC Evol Biol       Date:  2010-03-27       Impact factor: 3.260

Review 5.  Regulatory polymorphisms underlying complex disease traits.

Authors:  Julian C Knight
Journal:  J Mol Med (Berl)       Date:  2004-12-09       Impact factor: 4.599

6.  Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study.

Authors:  N C Olson; S Butenas; L A Lange; E M Lange; M Cushman; N S Jenny; J Walston; J C Souto; J M Soria; G Chauhan; S Debette; W T Longstreth; S Seshadri; A P Reiner; R P Tracy
Journal:  J Thromb Haemost       Date:  2015-09-14       Impact factor: 5.824

7.  Combined cis-regulator elements as important mechanism affecting FXII plasma levels.

Authors:  Maria Sabater-Lleal; Miguel Chillón; Carolina Mordillo; Angel Martínez; Estel Gil; José Mateo; John Blangero; Laura Almasy; Jordi Fontcuberta; José Manuel Soria
Journal:  Thromb Res       Date:  2009-09-27       Impact factor: 3.944

8.  Genome-wide association reveals that common genetic variation in the kallikrein-kinin system is associated with serum L-arginine levels.

Authors:  Weihua Zhang; Fredrik Jernerén; Benjamin C Lehne; Ming-Huei Chen; Robert N Luben; Carole Johnston; Amany Elshorbagy; Ruben N Eppinga; William R Scott; Elizabeth Adeyeye; James Scott; Rainer H Böger; Kay-Tee Khaw; Pim van der Harst; Nicholas J Wareham; Ramachandran S Vasan; John C Chambers; Helga Refsum; Jaspal S Kooner
Journal:  Thromb Haemost       Date:  2016-09-22       Impact factor: 5.249

9.  Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients.

Authors:  Georgios Athanasiadis; Esther Esteban; Magdanela Gayà Vidal; Robert Carreras Torres; Raoudha Bahri; Pedro Moral
Journal:  BMC Res Notes       Date:  2009-07-31

10.  Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes.

Authors:  Naoto Katakami; Mitsuyoshi Takahara; Hideaki Kaneto; Ikki Shimizu; Keizo Ohno; Fukashi Ishibashi; Takeshi Osonoi; Atsunori Kashiwagi; Ryuzo Kawamori; Iichiro Shimomura; Munehide Matsuhisa; Yoshimitsu Yamasaki
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.